Jong Hoon Kim

22PUBLICATIONS
101CO-AUTHORS
AllergyMajor global burdens of diseaseApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 28, 2025
Peripherally induced RORγt+ skin-resident regulatory T cells mediate the efficacy of allergen-specific immunotherapy.

|Apr 01, 2025
Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study.

Seong Jin Jo, Byung Soo Kim, Dong Hyun Kim

|Jun 14, 2024
Comparative study of efficacy and safety: Biosimilar rituximab versus originator rituximab in the treatment of pemphigus.

Sang Heon Shin, Jae Yeon Kim, Soo-Chan Kim

|Mar 08, 2024
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma.

Chang Gon Kim, Min Hee Hong, Dahee Kim

|Oct 13, 2023
Risk factors of rituximab-induced thrombocytopenia in patients with autoimmune bullous diseases.

Sang Gyun Lee, Soo-Chan Kim, Jong Hoon Kim

|Jun 26, 2023
A virtual memory CD8+ T cell-originated subset causes alopecia areata through innate-like cytotoxicity.

Joon Seok, Sung-Dong Cho, Jeongsoo Lee

Pageof 4

Frequent Collaborators

5 joint publications

Soo-Chan Kim

5 joint publications

Eui-Cheol Shin

4 joint publications

Su-Hyung Park

3 joint publications

Dae San Yoo